Medica Sur Clinic and Foundation. Liver Research Unit, Mexico City, Mexico.
Ann Hepatol. 2010 Oct-Dec;9(4):428-38.
Liver disease is a major health issue in Mexico. Although several studies have been performed to analyze the impact of liver diseases on the Mexican population, none has compared the prevalence and impact of liver disease between states within Mexico.
To analyze trends in mortality associated with liver diseases from 2000 to 2007 at the national and state levels.
Data was obtained from the Ministry of Health (number of deaths) and the National Population Council (CONAPO) (population at risk) and mortality rates were analyzed using statistical software.
Mortality due to viral hepatitis, liver tumors, and cirrhosis increased over the study period. Alcohol-related mortality decreased but was still the main cause of liver-related deaths. Viral hepatitis infection occurred predominantly in the northern states and liver tumors occurred predominantly in the central region. Alcohol-related deaths were elevated along the Pacific shoreline and deaths associated with cirrhosis occurred mainly in the central and southern states.
Incidence of liver-related mortality has increased and will continue to do so in the future.
肝脏疾病是墨西哥的一个主要健康问题。尽管已经进行了多项研究来分析肝脏疾病对墨西哥人口的影响，但尚无研究比较墨西哥各州之间肝脏疾病的患病率和影响。
分析 2000 年至 2007 年国家和州一级与肝脏疾病相关的死亡率趋势。
从卫生部（死亡人数）和国家人口委员会（CONAPO）（危险人群）获取数据，并使用统计软件分析死亡率。
病毒性肝炎、肝肿瘤和肝硬化导致的死亡率在研究期间有所上升。与酒精相关的死亡率下降，但仍是肝脏相关死亡的主要原因。病毒性肝炎感染主要发生在北部各州，肝肿瘤主要发生在中部地区。与酒精相关的死亡主要发生在太平洋沿岸，肝硬化相关的死亡主要发生在中部和南部各州。
与肝脏相关的死亡率的发生率已经增加，并将在未来继续增加。
